4//SEC Filing
Seidel-Dugan Cynthia 4
Accession 0000899243-21-018112
CIK 0001785530other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:31 PM ET
Size
7.9 KB
Accession
0000899243-21-018112
Insider Transaction Report
Form 4
Seidel-Dugan Cynthia
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2021-04-30+57,908→ 57,908 totalExercise: $16.00Exp: 2031-04-29→ Common Stock (57,908 underlying) - Award
Stock Option (right to buy)
2020-12-08+99,163→ 99,163 totalExercise: $4.77Exp: 2030-12-07→ Common Stock (99,163 underlying)
Footnotes (2)
- [F1]The option was granted on December 8, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through December 8, 2024.
- [F2]The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001857799
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 4:31 PM ET
- Size
- 7.9 KB